chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Increased upper airway secretion, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Chills and blocked sinuses for one night; blocked sinuses for onenight; since then sore throat with mucus accumulation overnight and cough; sore throat with mucus accumulation overnight; since then sore throat with mucus accumulation overnight and cough; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 02Apr2021(at the age of 31-years-old) as a single dose for COVID-19 immunisation. The medical history were reported as none. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on unknown date (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021, the patient experienced chills, blocked sinuses for one night and since then the patient had sore throat, mucus accumulation overnight and cough. On an unknown date, the patient underwent SARS-COV-2 test and the result was negative. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events chills, blocked sinuses for one night, sore throat, mucus accumulation overnight and cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus congestion
Clinical narrative: Chills and blocked sinuses for one night; blocked sinuses for onenight; since then sore throat with mucus accumulation overnight and cough; sore throat with mucus accumulation overnight; since then sore throat with mucus accumulation overnight and cough; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 02Apr2021(at the age of 31-years-old) as a single dose for COVID-19 immunisation. The medical history were reported as none. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on unknown date (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021, the patient experienced chills, blocked sinuses for one night and since then the patient had sore throat, mucus accumulation overnight and cough. On an unknown date, the patient underwent SARS-COV-2 test and the result was negative. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events chills, blocked sinuses for one night, sore throat, mucus accumulation overnight and cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: Later that evening, around 7:30pm "I" noticed what appears to be a rash that has developed on the top of "my" left hand.; It's a small, isolated, area with around seven bright red spots in varying sizes that has not spread; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 18Apr2021 at 10:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The medical history included adult attention deficit hyperactivity disorder(ADHD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the arm left on 24Mar2021 at 09:15 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 19:15, later that evening the patient noticed what appeared to be a rash that was developed on the top of his left hand. It was a small, isolated, area with around seven bright red spots in varying sizes that was not spread. The patient reported that there had been no itching, pain or sensitivity. It also appeared to be fading and it had been more than 72 hours at the time of this report since receiving the second dose. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash that has developed on the top of left hand and small, isolated, area with around seven bright red spots in varying sizes were recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm hurts extremely bad; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 21Apr2021 at 11:15, the patient experienced arm hurt extremely bad. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm hurt extremely bad was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Severe tinnitus after a few days in left ear mostly.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er 87 3u) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Concomitant medications included verapamil (MANUFACTURER UNKNOWN), hydrochlorothiazide/losartan potassium (HYZAAR) and atorvastatin (MANUFACTURER UNKNOWN); all for unknown indications, from an unknown date and unknown if ongoing. On 05Apr2021 at 12:00, the patient experienced severe tinnitus after a few days mostly in the left ear. The event resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures taken as a result of the reported event included treatment with CIPRODEX for ear from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe tinnitus after a few days in the left ear was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Body temperature, Chills, Decreased appetite, Fatigue
Clinical narrative: 2nd and 3rd day: tenderness under left arm (lymph nodes); Fatigue; Slight fever (100.2); Slight headache; Poor appetite; Chills at 12 hours; Soreness at vaccine site for at least 3 days; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 18Apr2021 at 11:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included moderate high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE), vitamin d nos (MANUFACTURER UNKNOWN), vitamin b nos (MANUFACTURER UNKNOWN) and alprazolam (XANAX); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced soreness at vaccine site for at least 3 days. On 18Apr2021 at 23:45, the patient experienced chills at 12 hours. On 19Apr2021, the next day, the patient experienced fatigue, slight fever (100.2), slight headache and poor appetite. On the same day, the patient underwent body temperature test and the result was 100.2 (units unspecified). On 20Apr2021, second and third day after vaccination, the patient experienced tenderness under left arm (lymph nodes). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness at vaccine site, chills, fatigue, slight fever (100.2), slight headache, poor appetite and tenderness under left arm (lymph nodes) was resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Vaccination site pain
Clinical narrative: 2nd and 3rd day: tenderness under left arm (lymph nodes); Fatigue; Slight fever (100.2); Slight headache; Poor appetite; Chills at 12 hours; Soreness at vaccine site for at least 3 days; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 18Apr2021 at 11:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included moderate high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE), vitamin d nos (MANUFACTURER UNKNOWN), vitamin b nos (MANUFACTURER UNKNOWN) and alprazolam (XANAX); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced soreness at vaccine site for at least 3 days. On 18Apr2021 at 23:45, the patient experienced chills at 12 hours. On 19Apr2021, the next day, the patient experienced fatigue, slight fever (100.2), slight headache and poor appetite. On the same day, the patient underwent body temperature test and the result was 100.2 (units unspecified). On 20Apr2021, second and third day after vaccination, the patient experienced tenderness under left arm (lymph nodes). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness at vaccine site, chills, fatigue, slight fever (100.2), slight headache, poor appetite and tenderness under left arm (lymph nodes) was resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Severe lymphadenopathy on both sides; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 07Apr2021 at 16:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 08Apr2021, the patient experienced severe lymphadenopathy on both sides that had lasted 2 weeks. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe lymphadenopathy on both sides was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Joint range of motion decreased, Malaise
Clinical narrative: painful left shoulder; joint pain; could not lift arm; Nausea; nausea feeling; Dizzy; dizziness; unwell feeling; tiredness; muscle pain; some chest pressure in her breathing; This is a spontaneous report from a contactable consumer. An 87-year-old female patient (reporter's wife) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 15Mar2021 (Lot Number: En6204) (at the age of 87 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history included COPD. The patient's concomitant medications were not reported. On 15Mar2021, the patient experienced a painful left shoulder, could not lift arm, nausea, and dizzy. The patient called the doctor's office and made an appointment. She discussed her nausea feeling and dizziness and was prescribed meclizine hydrochloride (12.5 mg tablet) which helped her feel better. Nausea feeling was under control after the second day. On unspecified dates in 2021, the patient experienced an unwell feeling, tiredness, muscle pain, joint pain, and some chest pressure in her breathing that went away after using some oxygen. After a few days, the patient seemed ok and the symptoms were minimal after that. The patient was recovering from the events.  No follow-up attempts are possible. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Painful respiration
Clinical narrative: painful left shoulder; joint pain; could not lift arm; Nausea; nausea feeling; Dizzy; dizziness; unwell feeling; tiredness; muscle pain; some chest pressure in her breathing; This is a spontaneous report from a contactable consumer. An 87-year-old female patient (reporter's wife) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 15Mar2021 (Lot Number: En6204) (at the age of 87 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history included COPD. The patient's concomitant medications were not reported. On 15Mar2021, the patient experienced a painful left shoulder, could not lift arm, nausea, and dizzy. The patient called the doctor's office and made an appointment. She discussed her nausea feeling and dizziness and was prescribed meclizine hydrochloride (12.5 mg tablet) which helped her feel better. Nausea feeling was under control after the second day. On unspecified dates in 2021, the patient experienced an unwell feeling, tiredness, muscle pain, joint pain, and some chest pressure in her breathing that went away after using some oxygen. After a few days, the patient seemed ok and the symptoms were minimal after that. The patient was recovering from the events.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Cough, Feeding disorder, Headache, Hyperhidrosis
Clinical narrative: Started with shot arm started to hurt four hours after shot got really bad; Body sweats; Body ached; Headache; Lots of snot and coughing didn't want to move; Couldn't eat; Drink felt nauseated; Lots of snot and coughing didn't want to move; Eye felt over used; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 17Apr2021 at 13:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy, allergy asthma, gastroesophageal reflux disease (GERD) and chronic obstructive pulmonary disease (COPD). Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. The concomitant medication included inhaler antibiotic (unspecified) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received surfed (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 17:00, four hours after shot the patient shot arm was started to hurt which was really bad, got body sweats, body ached, headache, eye felt over used, lots of snot and coughing, did not want to move, could not eat or drink, felt nauseated and only wanted to sleep for 2 days while each day got better. On day 3, the patient ate for the first time and on day 4 felt 90% better. The patient stated that, she did not know if she should get second shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shot arm started to hurt, body sweats, body ached, headache, eye felt over used, lots of snot and coughing, couldn't eat or drink and felt nauseated was resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Mucosal disorder, Nausea, Pain, Vaccination site pain
Clinical narrative: Started with shot arm started to hurt four hours after shot got really bad; Body sweats; Body ached; Headache; Lots of snot and coughing didn't want to move; Couldn't eat; Drink felt nauseated; Lots of snot and coughing didn't want to move; Eye felt over used; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 17Apr2021 at 13:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy, allergy asthma, gastroesophageal reflux disease (GERD) and chronic obstructive pulmonary disease (COPD). Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. The concomitant medication included inhaler antibiotic (unspecified) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received surfed (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 17Apr2021 at 17:00, four hours after shot the patient shot arm was started to hurt which was really bad, got body sweats, body ached, headache, eye felt over used, lots of snot and coughing, did not want to move, could not eat or drink, felt nauseated and only wanted to sleep for 2 days while each day got better. On day 3, the patient ate for the first time and on day 4 felt 90% better. The patient stated that, she did not know if she should get second shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shot arm started to hurt, body sweats, body ached, headache, eye felt over used, lots of snot and coughing, couldn't eat or drink and felt nauseated was resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Lymph nodes under arm are sore and nodes along collarbone are extremely sore.; Lymph nodes under arm are sore and nodes along collarbone are extremely sore and swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN8737) via an unspecified route of administration in the left arm on 15Apr2021 at 07:00 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. Medical history included depression. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received escitalopram (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN) and vortioxetine (MANUFACTURER UNKNOWN) for unspecified indication from unknown dates and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 16Mar2021 at 07:00 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced that lymph nodes under arm were sore and nodes along collarbone were extremely sore and swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Pyrexia, Vaccination site pain
Clinical narrative: Significant hair loss potentially caused by vaccine; Injection site pain; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 2955291-06152) via an unspecified route of administration in the left arm on 31Mar2021 at 08:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included seborrheic dermatitis, hair thinning, COVID-19 and known allergies to penicillin. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN), ketoconazole (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and minoxidil (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received sulfamethoxazole/trimethoprim (BACTRIM) on an unknown date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 19:30, the patient experienced injection site pain, chills and fever. On 13Apr2021, the patient experienced significant hair loss potentially caused by the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain, chills, fever and significant hair loss were unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Insomnia, Lymphadenopathy
Clinical narrative: Lymph nodes under left arm were significantly swollen; Felt significant pain under left arm; Unable to sleep through the night; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and known allergy to multiple foods. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient received morphine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP75533) via an unspecified route of administration in the left arm on 27Mar2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 20:30, couple hours after second shot, the patient started to feel significant pain under left arm. The next day the patient noticed that the lymph nodes under her left arm were significantly swollen, and was unable to sleep through the night due to the pain for 4 days, and did not go at physician but was planning to if the pain and swelling didn't start going down by day 5. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of event and included treatment with over the counter (OTC) medicines, paracetamol (TYLENOL), naproxen sodium (MOTRIN), ibuprofen (ALEVE), heat and cold to make the pain tolerable. The clinical outcome of the event felt significant pain under left arm, lymph nodes under left arm significantly swollen and unable to sleep was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pain, Painful respiration, Pyrexia
Clinical narrative: Fever above 38 degrees C; Pain during the night; Headache; Swollen injection site; Pain and bodyaches while breathing; Pain and bodyaches while breathing; This is a spontaneous report from a contactable consumer. A 34-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown whether the patient was pregnant at the time of vaccination. It was unknown whether prior to the vaccination, the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 04:00, the patient experienced fever above 38 degrees Centigrade, pain during the night, headache, swollen injection site and pain and body aches while breathing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether the patient received any treatment for the events. It was unknown whether since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events fever, pain during the night, headache, swollen injection site and pain and body aches while breathing were resolved on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Fever above 38 degrees C; Pain during the night; Headache; Swollen injection site; Pain and bodyaches while breathing; Pain and bodyaches while breathing; This is a spontaneous report from a contactable consumer. A 34-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown whether the patient was pregnant at the time of vaccination. It was unknown whether prior to the vaccination, the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 04:00, the patient experienced fever above 38 degrees Centigrade, pain during the night, headache, swollen injection site and pain and body aches while breathing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether the patient received any treatment for the events. It was unknown whether since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events fever, pain during the night, headache, swollen injection site and pain and body aches while breathing were resolved on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain
Clinical narrative: Several weeks since 2nd vaccine have had left neck pain and left inner knee pain; Several weeks since 2nd vaccine have had left neck pain and left inner knee pain; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multi vitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Mar2021 at 08:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 06Apr2021 at 05:00, several weeks since 2nd vaccine, the patient experienced left neck pain and left inner knee pain on daily and she did not normally experience these pains. She responded well to ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left neck pain and left inner knee pain was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Chills; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 20Apr2021 at 11:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 19:30, the patient experienced chills, fever and body aches 8 hours after vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, fever and body aches was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pyrexia
Clinical narrative: Fever; Dizzy/ Light-headed; Tired; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 at 11:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, cholesterol, triglycerides and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN), triamterene (MANUFACTURER UNKNOWN) and evolocumab (REPATHA); all for unknown indication from unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), ampicillin (MANUFACTURER UNKNOWN) and neomycin sulfate; polymyxin b sulfate; bacitracin (NEOSPORIN); all for unknown indication on unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Apr2021 at 11:30, the patient experienced fever, dizzy, light headed, tired and was not going away. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, dizzy, light-headed and tired was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Oral herpes
Clinical narrative: Suffering from a continuous cycle of fever blisters, aka cold sores on "my" lower lip.; Fatigued; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 13Mar2021(at the age of 40-years-old) as a single dose for COVID-19 immunisation. The medical history included asthma and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the arm left on an unknown date in Feb2021 at 11:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, since the second vaccine dose the patient had been suffering from a continuous cycle of fever blisters, aka cold sores on lower lip and also had been fatigued. The patient also reported that prior to vaccine she never had a single fever blister. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events fever blisters, aka cold sores on lower lip and included treatment with acyclovir (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever blisters, aka cold sores on lower lip and fatigued was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia, Thirst
Clinical narrative: Fever less than 24 hours later.; Chills less than 24 hours; Tired; Thirsty; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 m-RNA Vaccine; Lot Number: WE0161) via an unspecified route of administration in the right arm on 15Apr2021 at 16:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy and asthma. Prior to the vaccination, the patient was not  diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 12.00, the patient experienced fever and chills less than twenty four hours. The patient was tired and thirsty as well. No therapeutic measures were taken as results of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever, chills less than 24 hours, tired and thirsty as well was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Extreme itching on hands and feet; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old, male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 16Apr2021 at 13:45 in right arm (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications within 2 weeks of vaccination included cetirizine hydrochloride (ALLER-TEC) started on an unknown date for an unknown indication and unknown if ongoing. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 26Mar2021 at 15:00 in the right arm as a single dose for COVID-19 immunisation. On 19Apr2021, at 01:00, the patient experienced extreme itching on hands and feet. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event with benadryl and hydrocortisone cream.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme itching on hands and feet was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Feeling abnormal, Feeling cold, Headache
Clinical narrative: The skin on "my" entire face felt like it was on fire. "I" had to sleep with an icepack on it.; The rest of "my" body was cold and shivering.; Headache; Brain fog; Achy muscles; Swollen gland in "my" left armpit.; Trouble sleeping; The rest of "my" body was cold and shivering.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0169) via an unspecified route of administration in the arm left on 20Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included migraines, lasting effects from and flareups of mono when the patient was 17 and allergy to penicillin family. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the arm left on an unknown date in Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 03:00, the patient's skin on her entire face felt like it was on fire and had to sleep with an icepack on it. The rest of her body was cold and shivering, headache, brain fog, achy muscles, swollen gland in left armpit and trouble sleeping. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events skin on entire face felt like it was on fire, rest of body was cold and shivering, headache, brain fog, achy muscles, swollen gland in left armpit and trouble sleeping were recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Lymphadenopathy, Myalgia
Clinical narrative: The skin on "my" entire face felt like it was on fire. "I" had to sleep with an icepack on it.; The rest of "my" body was cold and shivering.; Headache; Brain fog; Achy muscles; Swollen gland in "my" left armpit.; Trouble sleeping; The rest of "my" body was cold and shivering.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0169) via an unspecified route of administration in the arm left on 20Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included migraines, lasting effects from and flareups of mono when the patient was 17 and allergy to penicillin family. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the arm left on an unknown date in Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 03:00, the patient's skin on her entire face felt like it was on fire and had to sleep with an icepack on it. The rest of her body was cold and shivering, headache, brain fog, achy muscles, swollen gland in left armpit and trouble sleeping. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events skin on entire face felt like it was on fire, rest of body was cold and shivering, headache, brain fog, achy muscles, swollen gland in left armpit and trouble sleeping were recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.